The COVID19 Antigen Rapid Test (ART) Kit by Roche Diagnostics (also known as SARS-CoV-2 Antigen Self Test Nasal kit) provides reliable results for individuals suspected of having COVID-19. The Self Test can be performed by the general public, providing another option for decentralized testing. Testing whenever and wherever needed can be the basis for safer decision making and a step towards more normality for everyone. This test kit is a lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in human nasal samples. This test is used to detect antigens of the SARS-CoV-2 virus in individuals suspected of having COVID-19 and is designed as a self-test for the general public.

The benefit of having a SARS-CoV-2 antigen test available

The SARS-CoV-2 virus causes respiratory tract infection. It is transmitted mainly via respiratory droplets after close contact, and primary viral replication is presumed to occur in mucosal epithelium of the upper respiratory tract (nasal cavity and pharynx).2 At these locations viral load peaks within the first week after symptom onset, and then declines.3

A SARS-CoV-2 antigen test detects the presence of the SARS-CoV-2 virus from part of the upper respiratory tract swab specimens by identifying a nucleoprotein that is carried by the virus. The test identifies current infection during the acute phase of COVID-19, while the virus is still present in large quantities in the respiratory tract.

Produced by Roche Diagnostics, we believe wide accessibility to such high-performance, instrument-free and reliable Point of Care tests can contribute significantly to better managing the ongoing pandemic crisis.